Today, the good news is that four million HIV-positive people are alive on antiretroviral therapy (ART). The bad news is that MSF teams working to treat HIV/AIDS are witnessing worrying signs of waning international support to combat HIV/AIDS.

More >

But just as important gains are beginning to show their promise for patients, a stagnation in donor funding, coupled with trade policies that will create serious additional barriers to accessing affordable generic medicines, are dealing HIV/AIDS treatment a double blow.

More >

While several countries hardest hit by the AIDS epidemic are improving HIV treatment protocols to reduce deaths and illness, a lack of support from donors prevents many from implementing vital changes.

More >